Signite Partners - aVenture Asset Manager Research
Signite Partners
Operating Status: Operating
Signite Partners: The venture capital division of Shinsegae Group.
Location
Seoul, KR
Founded
2020
Signite Partners, the venture capital arm of Shinsegae Group, focuses on investing in innovative companies across various sectors. While their specific investment stages and typical investment sizes are not explicitly stated, their portfolio suggests a preference for Series A and Series B rounds.
Notable portfolio companies include Cipherome, Genome Insight, and Rael, with total funding ranging from $19.5 million to $35 million. As part of the Shinsegae Group, Signite Partners likely leverages its parent company's extensive resources and network to support its portfolio companies' growth and development.
Signite Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count5
Top Investment Stages
Series B4 (80.0%)
Series A1 (20.0%)
Stage Mix
Series B 80%Series A 20%
Concentration shown as share of disclosed investments by stage.